Close
Nordic 9Nordic 9

Sciencons (investor - Others)

Norway
See something wrong or missing? Let us know
Offices:Oslo
Average round investment:4.11M USD
Average number per year:1.0
Distribution: 2020 (1)
Portfolio companies: Norway Oncoinvent
Mostly invests in: Norway Norway (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sciencons

Name Criteria
Norway Alpine Capital AS
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Artal AS
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Inven2
70%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Norway Sintef TTO
68%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
France Advent France Biotechnology
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Axilium Capital
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Simon Capital
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Break Off Capital
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Broadview Ventures
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain CG Health Ventures
66%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top